Showing results (71-80 of 124) with videos related to
Sort By:
Pageof 13
Medical Oncology (Northwood, London, England)|September 17, 2009
Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGETS Negrier, E Jäger, C Porta, et al.Cancer|October 1, 1992
Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapyJ Bellmunt, J Albanell, O S Gallego, et al.European Journal of Cancer (Oxford, England : 1990)|July 26, 2000
Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancerJ Bellmunt, V Guillem, L Paz-Ares, et al.The Journal of Pathology|July 19, 2008
Discovery of myopodin methylation in bladder cancerV Cebrian, M Alvarez, A Aleman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Five-day course of granulocyte colony-stimulating factor in patients with prolonged neutropenia after adjuvant chemotherapy for breast cancer is a safe and cost-effective schedule to maintain dose-intensityA Ribas, J Albanell, J Bellmunt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerM Pera, R Gallego, C Montagut, et al.Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease]A Heidenreich, J Bellmunt, M Bolla, et al.Actas Urologicas Espanolas|July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]N Mottet, J Bellmunt, M Bolla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancerJ Carles, E Esteban, M Climent, et al.Anticancer Research|March 1, 1996
Node-negative breast cancers with p53(-)/HER2-neu(-) status may identify women with very good prognosisJ Albanell, J Bellmunt, R Molina, et al.Pageof 13